Evaluation of Wearable Digital Devices in a Phase I Clinical Trial

Evaluation of Wearable Digital Devices in a Phase I Clinical Trial

We assessed the performance of two US Food and Drug Administration (FDA) 510(k)‐cleared wearable digital devices and the operational feasibility of deploying them to augment data collection in a 10‐day residential phase I clinical trial. The Phillips Actiwatch Spectrum Pro (Actiwatch) was used to as...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena S. Izmailova (Author), Ian L. McLean (Author), Gaurav Bhatia (Author), Greg Hather (Author), Matthew Cantor (Author), David Merberg (Author), Eric D. Perakslis (Author), Christopher Benko (Author), John A. Wagner (Author)
Format: Book
Published: Wiley, 2019-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items